Neuphoria Therapeutics Inc.
NEUP
$4.96
$0.1152.38%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.34M | 8.08M | 12.61M | 12.61M | 10.13M |
| Total Receivables | 35.60K | 116.00K | 126.90K | 126.90K | 423.30K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 18.50K | 231.10K | 458.80K | 458.80K | 933.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 4.40M | 8.43M | 13.19M | 13.19M | 11.49M |
|
|
|||||
| Total Current Assets | 4.40M | 8.43M | 13.19M | 13.19M | 11.49M |
| Net Property, Plant & Equipment | 152.20K | 199.40K | 219.00K | 219.00K | 283.70K |
| Long-term Investments | 8.41M | 8.90M | 8.69M | 8.69M | 8.83M |
| Goodwill | 8.41M | 8.90M | 8.69M | 8.69M | 8.83M |
| Total Other Intangibles | 5.14M | 5.30M | 5.47M | 5.47M | 5.80M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 74.00K | 82.50K | 78.80K | 78.80K | 81.10K |
| Total Assets | 18.17M | 22.92M | 27.65M | 27.65M | 26.48M |
|
|
|||||
| Total Accounts Payable | 1.53M | 1.33M | 2.24M | 2.24M | 1.75M |
| Total Accrued Expenses | 484.50K | 1.10M | 1.46M | 1.46M | 382.10K |
| Short-term Debt | -- | -- | -- | -- | 765.30K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 118.50K | 129.90K | 122.00K | 122.00K | 120.40K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 2.13M | 2.55M | 3.83M | 3.83M | 3.02M |
|
|
|||||
| Total Current Liabilities | 2.13M | 2.55M | 3.83M | 3.83M | 3.02M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | 765.30K |
| Capital Leases | 49.80K | 89.50K | 117.60K | 117.60K | 185.50K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.24M | 3.21M | 6.21M | 6.21M | 3.49M |
| Total Liabilities | 4.42M | 5.85M | 10.16M | 10.16M | 6.69M |
|
|
|||||
| Common Stock & APIC | 198.19M | 198.28M | 198.48M | 198.48M | 159.39M |
| Retained Earnings | -180.73M | -178.78M | -177.98M | -177.98M | -149.03M |
| Treasury Stock & Other | -3.72M | -2.43M | -3.01M | -3.01M | 9.43M |
| Total Common Equity | 13.75M | 17.07M | 17.49M | 17.49M | 19.79M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 13.75M | 17.07M | 17.49M | 17.49M | 19.79M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 13.75M | 17.07M | 17.49M | 17.49M | 19.79M |
|
|
|||||
